{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:22:10Z","timestamp":1772223730914,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.03.036","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T12:30:11Z","timestamp":1082723411000},"page":"3698-3706","source":"Crossref","is-referenced-by-count":22,"title":["Persistent itching nodules after the fourth dose of diphtheria\u2013tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium"],"prefix":"10.1016","volume":"22","author":[{"given":"E","family":"Netterlid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bruze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hinds\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Olin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.03.036_BIB1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0264-410X(03)00531-0","article-title":"Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer","volume":"22","author":"Bergfors","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1398-9995.1985.tb00249.x","article-title":"Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts","volume":"40","author":"Frost","year":"1985","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0536.1986.tb01368.x","article-title":"Contact sensitivity to aluminium","volume":"15","author":"B\u00f6hler-Sommeregger","year":"1986","journal-title":"Contact Dermat."},{"key":"10.1016\/j.vaccine.2004.03.036_BIB4","first-page":"1900","article-title":"Aluminiumallergi for\u00e5rsaget af Di-Te-Pol-vaccine","volume":"154","author":"Nielsen","year":"1992","journal-title":"Ugeskr L\u00e6ger"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0264-410X(94)90119-8","article-title":"Adverse reaction after diphtheria\u2013tetanus booster in 10 year-old schoolchildren in relation to the type of vaccine given for the primary vaccination","volume":"5","author":"Blennow","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB6","first-page":"159","article-title":"The role of aluminium for adverse reactions and immunogenicity of diphtheria\u2013tetanus booster vaccine","volume":"82","author":"Mark","year":"1993","journal-title":"Acta P\u00e6diatr"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A Placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2004.03.036_BIB8","doi-asserted-by":"crossref","unstructured":"Wahlberg JE. Patch testing. In: Rycroft RJG, Menn\u00e9 T, Frosch PJ, Lepoittevin, J-P, editors. Textbook of contact dermatitis. 3rd ed. Berlin, Heidelberg, New York: Springer Verlag; 2001. p. 435\u201368.","DOI":"10.1007\/978-3-662-10302-9_21"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB9","first-page":"287","article-title":"Terminology of contact dermatitis","volume":"50","author":"Wilkinson","year":"1970","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.vaccine.2004.03.036_BIB10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ije\/28.2.319","article-title":"Simple sample size calculation for cluster-randomized trials","volume":"28","author":"Hayes","year":"1999","journal-title":"Int J Epid"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","article-title":"Macrophagic myofasciitis: an emergin entity","volume":"352","author":"Gherardi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB12","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10024001-0137-8","article-title":"Aluminium phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis","volume":"5","author":"Lacson","year":"2002","journal-title":"Pediatr Develop Pathol"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB14","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0264-410X(02)00171-8","article-title":"Lack of consistent relationship between quantity of aluminium in diphtheria\u2013tetanus\u2013acellular pertussis vaccines and rates of extensive swelling reactions","volume":"20","author":"Rennels","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB15","first-page":"1","article-title":"Vaccination granulomas","volume":"16","author":"R\u00f8nne","year":"1999","journal-title":"Epi-News"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0536.1992.tb00123.x","article-title":"Vaccination granulomas and aluminium allergy: course and prognostic factors","volume":"26","author":"Kaaber","year":"1992","journal-title":"Contact Dermat."},{"key":"10.1016\/j.vaccine.2004.03.036_BIB17","unstructured":"Hewlett EL. Preparation and composition of acellular pertussis vaccines. Considerations of potential effects on vaccine efficacy. In: Brown E, Greco D, Mastrantonio P, Salmaso S, editors. Pertussis vaccine trials, Basel. Dev Biol Stand 1997;89:143\u201351."},{"key":"10.1016\/j.vaccine.2004.03.036_BIB18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0264-410X(97)00067-4","article-title":"Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines","volume":"15","author":"Duch\u00e9n","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.036_BIB19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","article-title":"Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence","volume":"4","author":"Jefferson","year":"2004","journal-title":"Lancet Infect. Dis."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:50:23Z","timestamp":1549785023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":19,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002841"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}